Albuterol and Occlusion - renal artery - a phase IV clinical study of FDA data

Summary:

Occlusion - renal artery is found among people who take Albuterol, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Albuterol and have Occlusion - renal artery. It is created by eHealthMe based on reports of 133,133 people who have side effects when taking Albuterol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 24, 2023

133,133 people reported to have side effects when taking Albuterol.
Among them, 31 people (0.02%) have Occlusion - renal artery.


What is Albuterol?

Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 134,909 Albuterol users for its effectiveness, alternative drugs and more.

What is Occlusion - renal artery?

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) is found to be associated with 1,224 drugs and 704 conditions by eHealthMe.

Number of Albuterol and Occlusion - renal artery reports submitted per year:

Could Albuterol cause Occlusion - renal artery?

Gender of people who have Occlusion - renal artery when taking Albuterol *:

  • female: 67.74 %
  • male: 32.26 %

Age of people who have Occlusion - renal artery when taking Albuterol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 12.5 %
  • 50-59: 29.17 %
  • 60+: 58.33 %

Common drugs people take besides Albuterol *:

  1. Lisinopril: 14 people, 45.16%
  2. Aspirin: 14 people, 45.16%
  3. Lasix: 11 people, 35.48%
  4. Coreg: 9 people, 29.03%
  5. Spironolactone: 8 people, 25.81%
  6. Digoxin: 8 people, 25.81%
  7. Plavix: 8 people, 25.81%
  8. Nitroglycerin: 8 people, 25.81%
  9. Coumadin: 8 people, 25.81%
  10. Ativan: 7 people, 22.58%

Common side effects people have besides Occlusion - renal artery *:

  1. High Blood Pressure: 16 people, 51.61%
  2. Cardiac Failure Congestive: 12 people, 38.71%
  3. Renal Failure Chronic (long lasting kidney dysfunction): 10 people, 32.26%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 32.26%
  5. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 9 people, 29.03%
  6. Chest Pain: 9 people, 29.03%
  7. Breathing Difficulty: 8 people, 25.81%
  8. Mitral Valve Incompetence (inefficient heart valve): 8 people, 25.81%
  9. Pain In Extremity: 8 people, 25.81%
  10. Weakness: 8 people, 25.81%

Common conditions people have *:

  1. High Blood Pressure: 5 people, 16.13%
  2. Indigestion: 4 people, 12.90%
  3. Poor Quality Sleep: 3 people, 9.68%
  4. Occipital Neuralgia (condition characterized by chronic pain in the upper neck): 3 people, 9.68%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.68%
  6. Sleep Disorder: 3 people, 9.68%
  7. High Blood Cholesterol: 3 people, 9.68%
  8. Pain: 2 people, 6.45%
  9. Stress And Anxiety: 2 people, 6.45%
  10. Breathing Difficulty: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Albuterol and have Occlusion - renal artery?

Check whether Occlusion - renal artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Occlusion - renal artery and when was it recovered:

Expand to all the drugs that have ingredients of albuterol:

Alternative drugs to, pros and cons of Albuterol:

Common Albuterol side effects:

Browse all side effects of Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Occlusion - renal artery treatments and more:

COVID vaccines that are related to Occlusion - renal artery:

Common drugs associated with Occlusion - renal artery:

All the drugs that are associated with Occlusion - renal artery:

Common conditions associated with Occlusion - renal artery:

All the conditions that are associated with Occlusion - renal artery:

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Albuterol) and Albuterol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: